135 related articles for article (PubMed ID: 37236165)
1. Synthesis of 1,2,3-triazole-1,3,4-thiadiazole hybrids as novel α-glucosidase inhibitors by in situ azidation/click assembly.
Kumar H; Dhameja M; Kurella S; Uma A; Gupta P
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300145. PubMed ID: 37236165
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
8. Flavone-1,2,3-triazole derivatives as potential α-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis and molecular docking study.
Dhameja M; Kumar H; Kurella S; Uma A; Gupta P
Bioorg Chem; 2022 Oct; 127():106028. PubMed ID: 35868105
[TBL] [Abstract][Full Text] [Related]
9. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
11. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
13. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
[TBL] [Abstract][Full Text] [Related]
14. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
15. New biologically dynamic hybrid pharmacophore triazinoindole-based-thiadiazole as potent α-glucosidase inhibitors: In vitro and in silico study.
Khan AA; Rahim F; Taha M; Rehman W; Iqbal N; Wadood A; Ahmad N; Shah SAA; Ghoneim MM; Alshehri S; Salahuddin M; Khan KM
Int J Biol Macromol; 2022 Feb; 199():77-85. PubMed ID: 34968547
[TBL] [Abstract][Full Text] [Related]
16. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors.
Iraji A; Shareghi-Brojeni D; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
Sci Rep; 2022 May; 12(1):8647. PubMed ID: 35606520
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1,2,3,triazole modified analogues of hydrochlorothiazide via click chemistry approach and in-vitro α-glucosidase enzyme inhibition studies.
Siddiqui H; Baheej MAA; Ullah S; Rizvi F; Iqbal S; Haniffa HM; Wahab AT; Choudhary MI
Mol Divers; 2022 Aug; 26(4):2049-2067. PubMed ID: 34608550
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors.
Zhao X; Zhan X; Zhang H; Wan Y; Yang H; Wang Y; Chen Y; Xie W
Bioorg Med Chem Lett; 2021 Dec; 54():128447. PubMed ID: 34767915
[TBL] [Abstract][Full Text] [Related]
20. Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.
Abuelizz HA; Anouar EH; Ahmad R; Azman NIIN; Marzouk M; Al-Salahi R
PLoS One; 2019; 14(8):e0220379. PubMed ID: 31412050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
